| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 02/20/2013 | EP2558467A1 Aryl - /heteroaryl - cyclohexenyl - tetraazabenzo [e]azulenes as vasopressin antagonists |
| 02/20/2013 | EP2558465A1 Tricyclic pyridyl-vinyl pyrroles as par1 inhibitors |
| 02/20/2013 | EP2558454A2 Androgen induced oxidative stress inhibitors |
| 02/20/2013 | EP2558445A1 Intermediates useful for the synthesis of pyrrolobenzodiazepines |
| 02/20/2013 | EP2558099A2 Kinase inhibitors |
| 02/20/2013 | CN102939292A Spirocyclic compounds and their use as therapeutic agents and diagnostic probes |
| 02/20/2013 | CN102939283A Indazole compounds useful as ketohexokinase inhibitors |
| 02/20/2013 | CN102939088A Anti-viral compounds |
| 02/20/2013 | CN102936259A Method for synthesizing cucurbit [6] uril, Q[6]-rear earth linear polymer and separating light rear earth from heavy rear earth |
| 02/20/2013 | CN102936258A Cucurbit [7] uril-rare earth tubular polymer induced by tetrachloro zinc acidic group and synthetic method thereof |
| 02/20/2013 | CN102936255A Separation method for Q[5]@Q[10] |
| 02/20/2013 | CN102936251A Preparation method of pyrrolo[2,3-d]pyrimidine derivative |
| 02/20/2013 | CN102936250A 稠合双环mTOR抑制剂 Fused bicyclic inhibitors of mTOR |
| 02/20/2013 | CN102936249A Halogenated piperazinium compound |
| 02/20/2013 | CN102935230A Use of RNAi inhibiting PARP activtiy for the manufacture of a medicament for the treatment of cancer |
| 02/20/2013 | CN101679442B Compounds for the treatment of hepatitis c |
| 02/20/2013 | CN101277700B Pyrimidine compounds as serotonin receptor modulators |
| 02/19/2013 | US8378093 Explosives detection markers |
| 02/19/2013 | US8377946 Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors |
| 02/19/2013 | US8377922 Benzazepinone compound |
| 02/19/2013 | CA2716856C Aurora kinase modulators and method of use |
| 02/19/2013 | CA2562780C Nucleic acid melting analysis with saturation dyes |
| 02/19/2013 | CA2532798C Azepine derivatives as pharmaceutical agents |
| 02/14/2013 | WO2013022919A1 P62-zz chemical inhibitor |
| 02/14/2013 | WO2013022818A1 Novel macrocycles as factor xia inhibitors |
| 02/14/2013 | WO2013022814A1 Cyclic p1 linkers as factor xia inhibitors |
| 02/14/2013 | WO2013021054A1 Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1h-[1,8]naphthyridinones |
| 02/14/2013 | WO2013021044A1 1,2,4-triazolyl-substituted keto-enols |
| 02/14/2013 | WO2013020164A1 Compounds for treating respiratory syncytial virus infections |
| 02/14/2013 | US20130041307 Application of beta-functionalized dihydroxy-chlorins for pdt |
| 02/14/2013 | US20130041150 Process for the preparation of chiral beta amino carboxamide derivatives |
| 02/14/2013 | US20130040986 Modulators of Cystic Fibrosis Transmembrane Conductance Regulator |
| 02/14/2013 | US20130040973 JAK PI3K/mTOR COMBINATION THERAPY |
| 02/14/2013 | US20130040971 6-cycloalkyl-pyrazolopyrimidinones for the treatment of cns disorders |
| 02/14/2013 | US20130040970 Co-Crystals Of A Triazolo [4,5-D] Pyrimide Platelet Aggregation Inhibitor |
| 02/14/2013 | US20130040955 6-cycloalkyl-pyrazolopyrimidinones for the treatment of cns disorders |
| 02/14/2013 | US20130040949 Type ii raf kinase inhibitors |
| 02/14/2013 | US20130040946 Substituted imidazopyrimidines and triazolopyrimidines |
| 02/14/2013 | US20130040943 Tricyclic pyridyl-vinyl pyrroles as par1 inhibitors |
| 02/14/2013 | US20130040934 Spirocyclic compounds and their use as therapeutic agents and diagnostic probes |
| 02/14/2013 | US20130040924 Bridged polycyclic compound based compositions for the inhibition and amelioration of disease |
| 02/14/2013 | US20130039976 Sodium channel blocker for treatment of loss of superficial sensitivity |
| 02/14/2013 | US20130039858 Nir materials and nanomaterials for theranostic applications |
| 02/14/2013 | US20130037752 Electroluminescent materials comprising fluorene derivatives |
| 02/14/2013 | CA2855948A1 1,2,4-triazolyl-substituted keto-enols |
| 02/14/2013 | CA2844254A1 Novel macrocycles as factor xia inhibitors |
| 02/14/2013 | CA2842518A1 Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1h-[1,8]naphthyridinones |
| 02/13/2013 | EP2557080A1 Method for identifying pI3-kinase antagonists |
| 02/13/2013 | EP2556075A1 Substituted carbazole derivatives and use thereof in organic electronics |
| 02/13/2013 | EP2556074A1 Tricyclic indazole compound, method of preparation and pharmaceutical composition containing it |
| 02/13/2013 | EP2556073A1 Bicyclic pyrimidinyl pyrazoles |
| 02/13/2013 | EP2555617A1 Novel hypoglycemic compounds |
| 02/13/2013 | CN102933588A Covalent organic frameworks and methods of making same |
| 02/13/2013 | CN102933584A Pyrrolopyrazinone inhibitors of kinases |
| 02/13/2013 | CN102933583A Heteroaryl imidazolone derivatives as JAK inhibitors |
| 02/13/2013 | CN102933582A Substituted carbazole derivatives and use thereof in organic electronics |
| 02/13/2013 | CN102933236A Pyrrolobenzodiazepines and conjugates thereof |
| 02/13/2013 | CN102924463A Multi-anchor self-assembled porphyrin and synthetic method thereof |
| 02/13/2013 | CN102924462A Method for synthesis of 1,2,3,4,5,9-substituted benzazepine compound |
| 02/13/2013 | CN102924461A Ternary electric memory material of azo chromophore of imide framework, as well as preparation and application of ternary electric memory material |
| 02/13/2013 | CN102924460A 4H-pyrrolo[1, 2-a] benzimidazole derivative and synthesizing method and application thereof |
| 02/13/2013 | CN102924459A Synthetic method of pyrrole fused-ring 3-indolone type compounds |
| 02/13/2013 | CN102924458A 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| 02/13/2013 | CN102924457A Triazolopyrimidine derivatives, preparation method and uses thereof |
| 02/13/2013 | CN102924217A Fluorene and pyrene derivatives and organic electroluminescent device using the same |
| 02/13/2013 | CN102921463A Nano zinc sulfide metalloporphyrin catalyst and preparation method and application thereof |
| 02/12/2013 | US8372981 Nitrogen-containing aromatic derivatives |
| 02/12/2013 | US8372976 Methods of treatment comprising the administration of heteroaryl compounds |
| 02/12/2013 | US8372854 Pyrrolo[2,3-D]pyrimidine compounds |
| 02/12/2013 | US8372852 Purines as reverse transcriptase inhibitors |
| 02/12/2013 | US8372851 Pyrazolo pyrimidines as casein kinase II (CK2) modulators |
| 02/12/2013 | US8372831 Isoxazoline linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids as potential anticancer agents and the process for preparation thereof |
| 02/12/2013 | US8372527 Material for organic electroluminescent element, and organic electroluminescent element |
| 02/12/2013 | CA2607441C Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 02/12/2013 | CA2596527C Igf-1r inhibitors |
| 02/12/2013 | CA2570155C 3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha.7-nachr ligands for the treatment of cns diseases |
| 02/07/2013 | WO2013019561A1 Nuclear transport modulators and uses thereof |
| 02/07/2013 | WO2013018899A1 Dibenzooxepin derivative |
| 02/07/2013 | WO2013018530A1 AMINOINDOLO[3,2,1-jk]CARBAZOLE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME |
| 02/07/2013 | WO2013016999A1 Heteroaryl-pyrimidine derivatives, and preparation method therefor and use thereof |
| 02/07/2013 | US20130035486 Processes for the preparation of sitagliptin and pharmaceutically acceptable salts thereof |
| 02/07/2013 | US20130035484 Intermediates useful for the synthesis of pyrrolobenzodiazepines |
| 02/07/2013 | US20130035349 Pyrazolopyrimidinone kinase inhibitor |
| 02/07/2013 | US20130035342 Compound Suitable for the Treatment of Synucleopathies |
| 02/07/2013 | US20130035334 Inhibitors of bruton's tyrosine kinase |
| 02/07/2013 | US20130035325 Kinase inhibitors |
| 02/07/2013 | US20130035324 Heterocyclic compounds and uses thereof |
| 02/07/2013 | US20130034616 Compounds useful as inhibitors of atr kinase |
| 02/07/2013 | US20130032787 Heterocyclic compound and organic light-emitting device including the same |
| 02/07/2013 | CA2842364A1 Nuclear transport modulators and uses thereof |
| 02/06/2013 | EP2554545A1 Carbazole-based compound and organic light-emitting diode comprising the same |
| 02/06/2013 | EP2552923A1 Macrocyclic integrase inhibitors |
| 02/06/2013 | EP2552922A1 Substituted pyrrolotriazines as protein kinase inhibitors |
| 02/06/2013 | EP2552921A1 Purine compounds |
| 02/06/2013 | EP2552920A1 Novel nk-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in nk-3 receptors mediated disorders |
| 02/06/2013 | EP2552919A1 Aryl-cyclohexyl-tetraazabenzo[e]azulenes |
| 02/06/2013 | EP2552918A1 N-(imidazopyrimidin-7-yl)-heteroarylamide derivatives and their use as pde10a inhibitors |
| 02/06/2013 | EP2552917A1 Process for synthesizing 6-bromo-3-(1-methyl-1h-pyrazol-4-yl)-5-(3(r)-piperidinyl)pyrazolo[1,5-a]pyrimidin-7-amine |
| 02/06/2013 | EP2552908A2 Heterocyclic compounds and their uses |
| 02/06/2013 | EP2552890A1 Polycyclic tetracycline compounds |